What the cardiothoracic surgeon of the twenty-first century ought to be  by Cohn, Lawrence H.
T o be president of The American Association forThoracic Surgery is, of course, the greatest honor of
our specialty. I remember my first AATS meeting in
1966 in Vancouver, when I stood at the back of the room
and looked at those Olympian figures, John Kirklin and
Denton Cooley, discussing fabulous topics of the time,
and I was just simply in awe of the whole proceedings.
Now I am here presenting my thoughts about the next
millennium to a new generation of thoracic surgeons.
This past year I have had the privilege to work with a
superb council, a responsive executive director, Bill
Maloney, and his staff, who do such an outstanding job
for our Association. I have also been blessed to work
with a talented and understanding staff, both attending
and resident, at the Brigham and Women’s Hospital.
I want to pay tribute to my wife, Roberta, for all of
her support, energy, and hard work on my behalf. As my
friend Rick Barner said at the meeting of the Southern
Thoracic Surgical Association, “Our wives work and
labor for us and our families so that we can enjoy and
selfishly indulge ourselves in surgery.” That could not
be more true in my case.
The title of my address, “What the Cardiothoracic
Surgeon of the Twenty-First Century Ought to Be,” may
ring a slightly familiar bell to those who are students of
surgical history. A variation of this title has been used
twice before. In the 14th century the French surgeon
Guy de Chauliac wrote, “What the Surgeon Ought to
Be.” More recently, in a Vascular Society presidential
address in 1972, Dr Glenn Morrow discussed, “What
the Cardiac Surgeon Ought to Be.”1 Using this para-
digm, I have chosen to discuss 11 individual qualities
that, I think, will be important for every cardiothoracic
surgeon in the 21st century. On this framework, I would
like to offer some reflections, some motivation, and also
some initiatives that we as individuals, and perhaps as a
specialty, should pursue.
The cardiothoracic surgeon of the 21st century
ought to be an excellent surgeon
Ultimately, the extent to which we will be judged as
practitioners of surgery will be determined by how
effectively we perform surgical procedures. In whatever
economic or institutional setting we work, we must
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strive to be the best technical surgeons that we can be
and ensure that our trainees be the best they can be.
Neither new technologies nor sophisticated postopera-
tive care techniques can ever compensate for a poorly
performed operation.
Equally important is the judgment used in determin-
ing the type of operation to be done. The surgeon
should be the one ultimately to decide who should have
what operation. Naturally, selection of patients and
operations involves both physician and surgeon, but in
the final analysis the surgeon has to be the one to make
these decisions and justify the rationale.
To continue to be an expert technical surgeon, how-
ever, we must know our own capabilities and results.
With the public increasingly looking at outcomes,2 we
need to be continually self-critical and willing to make
changes in techniques to improve outcomes. I person-
ally recall some suboptimal results my colleagues and I
had with reoperative coronary bypass about 10 years
ago, especially in patients with open, atherosclerotic
grafts. We subsequently adhered to a strict, “no-touch”
surgical strategy, and over the next 5 years the mortali-
ty for reoperative bypass was reduced to equal that of
primary coronary bypass.3
We are often asked to do operations on high-risk
patients as a last, desperate maneuver in a patient’s
course; outcomes of high-risk procedures may be part
of published results, but that should not deter our deci-
sion to operate if we believe we have the technical
expertise and the patient will benefit in the long-term.4
On the other hand, as Alfred Blalock, president of the
AATS in 1951, said, “The fact that a patient is going to
die does not necessarily mean that he should be operat-
ed upon.”1
The cardiothoracic surgeon of the 21st century
ought to be a physiologist
In the next century a growing number of new thera-
pies and new indications for standard therapies will
change what we do. Selection of operations and post-
operative care will be dictated by a thorough knowl-
edge not only of pathophysiology, but also of molecu-
lar biology. In this past decade, for example,
understanding the pathophysiology of mitral regurgita-
tion and its effect on left ventricular function has
allowed us to make more knowledgeable recommenda-
tions for surgery in both symptom-free and severely
compromised patients.
This is a far cry from 1966, when I worked in the lab-
oratory with Glenn Morrow at the National Institutes of
Health. Using relatively crude measurements of left
ventricular function by today’s standard, we conclu-
sively proved that the papillary muscle integrity had
absolutely no effect on postoperative function after
experimental mitral valve surgery.5 How wrong we
were! This misconception was promulgated for many
years until new experiments with more sophisticated
techniques and prospective clinical observations com-
pletely changed our thinking. We now know that
preservation of the papillary muscle–annular continuity
improves left ventricular function even in advanced
decompensation. This knowledge has stimulated many
to now do mitral valve repair rather than transplanta-
tion in some patients with severe heart failure, a con-
cept that was anathema to surgeons just a few years
ago.6
Similar changes in many therapies will be developed
on the basis new physiology and biology, and we must
be ready to learn and ready to change.
The cardiothoracic surgeon of the 21st century
ought to be an excellent teacher
Thoracic surgeons earn their teaching credentials
every day. We teach residents, support staff, referring
physicians, and colleagues, and by doing so we improve
the care of our patients. However, the educational agen-
da for the next century will be far more complex.
One of the most important education issues we face
is whether we should revise our residency training pro-
grams.7 The key question is this: With the increasing
amount of knowledge that we need to pass on to the
next generation of surgeons, should we increase the
length of time they spend in thoracic surgical training
and decrease the time in general surgical training? This
is being discussed now, not only because the knowl-
edge base is growing but also because there are in-
creasing concerns about the funding of graduate med-
ical education.8 Funding cutbacks, especially through
Medicare, may mandate both a reduced length of total
training and a reduced number of subspecialty resi-
dents.
My proposal is that we continue to work with our
general surgical colleagues toward developing an
excellent training curriculum in general surgery with a
flexible approach toward board certification, but at the
same time establish case benchmarking, especially for
gastrointestinal and vascular surgery. Most important,
we should provide expanded training in thoracic
surgery to teach our residents what they will need to
know in the next century. All of the major thoracic sur-
gical groups influencing education met recently to dis-
cuss these very issues. Working together, we should be
able to make these changes and still guarantee that our
residents will receive the best training possible.
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The cardiothoracic surgeon of the 21st century
ought to be very knowledgeable about the
economics of health care
In 1997 more than $1 trillion was spent on health
care in the United States, with $969 billion being spent
on personal health care.9 The complexities of this sys-
tem are so vast I thought I would just touch on just a
few areas of interest.
As we all know, data and performance measurements
are now the “buzz words” of health care manage-
ment.l0-12 Many state governments and payer coali-
tions, public and private, have developed economic and
medical outcome report cards on physicians and hospi-
tals. Cardiac surgery leads the way. The use of large
surgical databases, such as the Northern New England
database or the Society of Thoracic Surgeons database,
therefore, will be increasingly useful to learn who are
the most cost efficient, who do the best work, and what
new technologies are worth the expense. One feature
about database information has concerned me, and that
is the lack of a unified patient risk stratification system.
Without such a standard, comparison of database infor-
mation between hospitals, cities, regions, or care plans
may be misleading.13 Therefore I propose that the tho-
racic societies, directed by the Professional Affairs
Committee, stimulate discussion with major payers and
other health care agencies and organize the necessary
meetings to begin to formulate a truly universal risk
stratification scheme. This could help eliminate the
“gaming” of the system, prevent publication of inap-
propriate and misleading data, and discourage with-
holding of surgical therapy to the high-risk patient who
may benefit from surgery.
A second general area that concerns all of us, but one
that each of us needs to continually focus on, is the val-
idation of surgical procedures in elderly patients.14 As
the baby boomers age, the numbers of patients over 70
requiring cardiothoracic services will increase enor-
mously in the coming decades. Analysis of the costs
and benefits of the operative procedures we do in elder-
ly patients, especially those 80 and 90 years old, will be
important to ensure that we use our surgical expertise
to help those elderly patients who will truly benefit
from surgery by an improved quality of life and
increased longevity.
Finally, an economic area on which we need to
focus is capitated health care plans. There is no ratio-
nal reason why we who provide care to the seriously
ill should be in the business of denying care so that
third-party payers, many of whom are for-profit cor-
porations, can increase their bottom line. These sys-
tems are very costly for hospitals, especially the teach-
ing hospitals; they seriously erode our ability to pro-
vide free care, and they reduce funds for medical
research and teaching. The American people are now
resisting these programs, and I know in many areas
these programs are beginning to fall by the wayside,15
much to the chagrin of the myriads of well-paid non-
medical consultants who predicated otherwise.
Jerome Kassirer,16 editor of The New England Journal
of Medicine, summed this up best, when he recently
stated, “After all, what oath, promise or pledge did we
ever make, either as individuals or as a profession,
that obligates us to restrict care; we pledged instead to
provide care.”
The cardiothoracic surgeon of the 21st century
ought to be well versed in digital technology
In the past decade the boundaries between the digital
world of bits and the physical world of atoms have
been disappearing rapidly. We can now carry our “bits”
in our pockets with PalmPilot organizers (3Com
Corporation, Santa Clara, Calif), we have digital navi-
gation in our cars, and we can buy virtually anything
on-line.
What does this digital revolution mean to us? It
means that we are going to have to become fluent in the
range of opportunities offered by this new technology
and how they can be applied to our thoracic surgical
practice.
Most of us already use the Internet for information
retrieval, every journal is on-line, we communicate
with colleagues via the CTSNet, and we evaluate real-
time telemedicine consultations from around the world.
Digital technology will soon have a far wider reach in
the practice of medicine to include such advances as
wearable or implantable monitoring devices for home
patients with left ventricular assist devices, robotic car-
diothoracic surgery (already in its infancy), and state-
of-the art imaging techniques. Across the Charles River
from the Brigham at the Massachusetts Institute of
Technology, researchers are currently developing
advanced holographic imaging tools that will allow us
to view 3-dimensional images of organs instead of
using 2-dimensional magnetic resonance imaging or
computed tomographic scans. A start-up company, also
in the Massachusetts Institute of Technology area, is
working on a new magnetic resonance vascular imag-
ing process that will be able to accurately visualize the
coronary arteries in the beating heart without an inter-
ventional catheter.
As surgeons of the 21st century, we need to
understand and embrace these emerging digital
technologies.
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The cardiothoracic surgeon of the 21st century
ought to be knowledgeable, if not expert, about
advances in new surgical technology
Twelve years ago I17 gave a presidential address to
The American College of Chest Physicians, titled “The
Paradox of High-Tech Health Care,” in which I said
that our capability in cardiothoracic disease manage-
ment could be extended almost without limits by new
technology, but that these advances would be too
expensive to apply without limits. This was prophetic,
not surprisingly, since patients want these advance-
ments despite the cost, and predictably third-party pay-
ers resist paying the cost.
Understanding and learning how to use these tech-
nologies economically and responsibly will be one of
our toughest challenges for the new millennium. Take
for example the whole field of minimally invasive
surgery. After its beginning with the introduction of the
Fogarty arterial embolectomy catheter in 1963, there
was a great resistance to changing the old techniques.
Since then, minimally invasive approaches have
enhanced every field of surgery because, understand-
ably, patients want the same quality operation, with less
trauma, and a faster return to normal.
Many new technologies are being aggressively pro-
moted by device manufacturers, but how do we assim-
ilate them in a rational and cost-effective manner? As
with any new group of therapies, we should first be
appropriately skeptical before abandoning standard
approaches.18 Critical appraisals have to be done in
meetings such as the AATS, and in some cases prospec-
tive randomized studies of the new versus the standard,
or comparison with alternative nonsurgical interven-
tional procedures, may be necessary.
One of the most important questions will be this:
Who will organize and monitor the education and
assimilation of this new technology? In the November
issues of this Journal and The Annals of Thoracic
Surgery, the New Technology Committee published
education guidelines for minimally invasive heart
surgery.19a,19b Although only guidelines, we suggested
that there be multiple industrial sponsors for post-
graduate courses, formation of licensed proctoring
centers, and perhaps, in the future, even digital device
simulator centers for some technologies. Manu-
facturers with whom I have spoken are keenly aware
of the importance of teaching surgeons the right way
to use their technologies; however, they do not want to
be the only teachers, nor are they legally able to do
this. If we do not learn to teach new techniques to our
colleagues, the right way in the right patient, then
third-party agencies may jump in and dictate to us
what is good technology, who gets to do it, and what
gets reimbursed.
I recently attended an ad hoc meeting of surgical
society presidents sponsored by the American College
of Surgeons to discuss funding a pilot study to teach
new procedures to surgeons in all surgical specialties.
Programs like this must happen, and our organizations
must take the lead. The companies want this, surgeons
want this, and hospital credentialing boards want this.
People in this room and in this Association, not the
American Medical Association, not Blue Cross, must
determine the educational and hospital credentialing
guidelines for our specialty with new technology.
A cardiothoracic surgeon of the 21st century ought
to be a leader
The organization required to do heart surgery with
cardiopulmonary bypass or complicated thoracic surgi-
cal procedures thrusts us into a leadership position
every day because of the numbers of people who inter-
face on just a single complex thoracic operation.
Consider the organization and logistics required for a
recent simultaneous triple transplant performed by my
colleagues at the Brigham: two single lung transplants
and a heart transplant in three separate patients from
one donor, directing some 75 support staff.
However, the fact that we are thrust into leadership
positions does not necessarily mean we are good lead-
ers. Leadership is taking the responsibility to direct the
actions of others in carrying out the purposes of the
organization and with accountability for both success-
ful and failed endeavors. Leadership is determined by
being a role model and trying to be the best you can be,
it is the ability to make timely decisions, and it is car-
ing about all those who work for you and with you. In
his wonderful book, Leadership Secrets of Attila the
Hun, Wess Roberts20 states: “You must have a passion
to succeed, a passion that drives you to prepare your-
self and your colleagues to excel. By their actions, not
words, do leaders establish the morale and integrity of
their subordinates aided by the ability to make timely
difficult decisions.”
Now, more than ever, we must use our leadership
skills to broaden our scope and think in terms of hospi-
tal and national leadership to become spokespersons
for maintaining the highest quality and most cost-effec-
tive medical care. Many thoracic surgeons in the AATS
have already demonstrated superb leadership in major
health care institutions, regional and national medical
organizations, and even in high government office, but
this trend needs to increase if we want to be part of the
solution and not part of the problem.21,22
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The cardiothoracic surgeon of the 21st century
ought to be adaptable
The most successful thoracic surgeons are, by their
very nature, adaptable because they deal with new
predicaments every day in the operating room, on the
ward, and in the clinic.
In the coming years we will need to demonstrate this
adaptability in response to the changes in the treatment
of certain diseases. Although coronary artery disease is
one of the most common diseases in America, and is
certainly the most common disease for which we oper-
ate, treatment options are changing dramatically. I
recently read an article in Business Week, titled “Can
We End Heart Disease?”23 This article suggested the
possibility that because of increasingly successful
coronary interventions, angiogenesis, and genetic ther-
apy, we as surgeons may soon be out of work! I do not
believe this for a minute because of the surgical intel-
lect, ingenuity, and adaptability. Although I disagree
with the conclusion of the article, I do agree with the
assertion that, to be successful in treating coronary
artery disease, we are going to have to understand the
trends in these alternative methods to increase blood
supply to the heart and incorporate them into our sur-
gical treatment plans, including minimally invasive
coronary artery surgery.
Andy Grove,24 the founder of Intel Corporation, dis-
cusses this quality extensively in his book, Only the
Paranoid Survive. Grove believes that the more suc-
cessful you are the more susceptible to attack you are
from outside sources. His thesis revolves around “strate-
gic inflection points.” A strategic inflection point is a
time in the life of a business or organization or special-
ty when its fundamentals are about to change. That
change can mean an opportunity to rise to new heights
or may signal the beginning of the end. How adaptable
we are and how we respond when we hit these strategic
inflection points will dictate our future success. One of
the most important areas in which we have to be very
adaptable is in our collaboration with nonsurgical spe-
cialists. In my opinion, and it is shared by many others,
we will be best served by moving toward a “product” or
“service line” concept.11,12,25 A service line developed
jointly by cardiology and cardiac surgery or pul-
monology and thoracic surgery is the future. This con-
cept is especially good for the patient, de-emphasizing
competitive financial incentives between internist and
surgeon and promoting interrelating best therapies.
Such service lines have already been developed with
success at many institutions across the country.
Although this approach is going to bring about some
major changes in the classic academic departments, it
would appear to be the one plan that can ally specialists,
economically and therapeutically, in a more efficient
and cost-effective way. However, like any other major
change, it will necessitate adaptability and flexibility in
ourselves and the institutions in which we work.
The cardiothoracic surgeon of the 21st century
ought to be persistent
Persistence is perhaps the most important personal
quality in any successful cardiothoracic surgeon. How
many times has each of us experienced success in a
very difficult operation by simply adhering to our game
plan in the operating room, no matter what the obsta-
cles? This is one of the greatest lessons I learned as a
resident from my surgical mentor, Norman Shumway.
If things look bad, just keep working and collectively
figure out the simplest and safest way to achieve your
goal. I recall a patient with very complex congenital
heart disease on whom Shumway and I operated
together. After redoing baffles and anastomoses more
than once to achieve the correct physiologic anatomy,
we obtained an excellent outcome. For me, this was a
defining moment, and it has been a guiding principle in
my surgical practice.
This quality is as important for negotiations with
managed care as it is in the operating room. It is a qual-
ity we need in clinical and laboratory research, follow-
ing the example of Shumway, Lower, and Stofer, who
worked for 10 years to perfect orthotopic cardiac trans-
plantation. It is the same quality exhibited by members of
our professional affairs committee who labored for 5
years to understand the economics of health care, learn-
ing the “ins and outs” of Washington beltway interac-
tions, which eventually led to improved and slightly more
rational Medicare funding for cardiothoracic surgery.
Gustav Mahler, the great composer, once said, “For
success, nothing in the world can take the place of per-
sistence; talent alone will not be successful because
nothing is more common than the unsuccessful man
with talent. Education alone will not be successful,
because the world is full of educated fools. Persistence
and determination are alone, omnipotent.”26
The cardiothoracic surgeon of the 21st century
ought to have a good sense of the history of our
specialty
I firmly believe that a person can deal more intelli-
gently and more effectively with just about any subject
if he or she fully understands its evolution. How many
times have colleagues spun their wheels by simply not
checking the Internet or speaking to senior colleagues
about a “new” operation or case that is really not new.
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Owen Wangensteen27 once said, “If all problems in
medicine could be taught with special emphasis on a
historical approach, every physician would be better
prepared to cope with future problems.” Evaluating
new operations or trying new protocols that are not
observant of past data is sure folly, especially in this
age of accelerated information access. It took John
Gibbon more than 20 years to perfect the heart-lung
machine until his first clinical success in May 1953.
Even today, understanding his work is important for
anyone interested in developing cardiopulmonary
bypass techniques. I witnessed the signing of the
Medicare bill in 1965 by President Johnson on the lawn
of the National Institutes of Health. Understanding the
history of the subsequent twists and turns in this legis-
lation is important for understanding current health
care economic policy.
I have always been fascinated with history. My histor-
ical hero is Thomas Jefferson, about whom I have stud-
ied and written.28 Jefferson combined all of the intellec-
tual qualities that a good physician and surgeon ought to
have. He was inquisitive, he cared about people, and he
had a huge intellect, allowing him a unique perspective
on a vast array of subjects. He also was a firm believer in
the scientific method, and he criticized nonscientific
physicians of his time. He wrote in 1812, “While surgery
is seated in the temple of exact sciences, medicine has
scarcely entered its threshold, for their theories have
resulted in ... the necrology of man.”28 These qualities
exhibited by Thomas Jefferson are essential in our times,
when we must possess a significant background of expe-
rience and knowledge in almost everything we do.
The cardiothoracic surgeon of the 21st century,
above all, ought to be a humanist
Despite all of the advancements in technology and
the changes in the economy of health care, it is still
extremely important to be a good doctor and to demon-
strate compassion, a quality we as cardiothoracic sur-
geons are often criticized for lacking.
Being a cardiothoracic surgeon is enormously satis-
fying because it offers the most rapid gratification for
patient and physician, available in few specialties: one
can operate on a sick patient and make that person well
in a very short time, by performing a complex surgical
operation that is challenging both intellectually and
physically. However, we have to remember the human-
istic side of each operation we do.
On a personal note, as many of you know, about a year
and a half ago I underwent a minimally invasive aortic
valve replacement performed by our vice president. As a
patient I found it comforting and confidence building to
receive kind, thoughtful, and intelligent care. In return, I
found that care was maximized when I, as a patient, gave
back kindness and appreciation. During my hospital
stay, one of the most important times of each day was
when my surgeon came in late at night to make his
rounds, shake my hand, and discuss my progress. There
was an uplifting of spirits that made me feel better in
every way, and I was encouraged that I would recover. It
is important, if for only a brief social visit, to touch each
patient, to give him or her confidence, and describe how
things are progressing and why. I also now truly under-
stood how important a supportive family is to a recover-
ing surgical patient. I believe my personal experience
has made me a better physician.
Conclusion
These are some of the qualities that I think will be very
important for cardiothoracic surgeons as we enter the
21st century. They will be necessary to meet the chal-
lenges presented by the changing pathophysiology of
diseases, by changing therapies, and by the commingling
with interventional specialists in all areas of thoracic
surgery. Superimposed on this new knowledge base will
be vastly changing technology and new health care eco-
nomics that are going to alter the way we practice and
the way we are reimbursed for our surgical skills.
I hope these remarks have some relevance for all of
you, and I hope many of these qualities will be learned,
enjoyed, critically evaluated, and openly embraced as
we enter the new millennium.
The Association has honored me by electing me to
serve as its 79th president, and I am deeply grateful.
Thank you very much.
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